Literature DB >> 17239035

Reliability and validity of the Turkish form of the Somatosensory Amplification Scale.

Hüseyin Güleç1, Kemal Sayar.   

Abstract

In this study, the authors aimed to investigate the reliability and validity of the Somatosensory Amplification Scale (SSAS) that was developed by Barsky et al. in the Turkish population. The study was carried out with 42 patients with Fibromyalgia Syndrome and Asthma Diseases attending to outpatient Physical Therapy and Rehabilitation and Chest Diseases clinics and 86 healthy students from Karadeniz Technical University. SSAS scores were normally distributed, and had acceptable test-retest reliability (r: 0.73) and internal consistency (alpha, 0.62-0.76). Item to scale correlations varied from 0.10 to 0.72, and most were highly significant. Whereas, one item (item 1) in the control group and one item (item 2) in the patients group had low item-total score correlation (r < 0.15). Criterion related validity of the SSAS was shown with significant correlation between the Symptom Interpretation Questionnaire, the Toronto Alexithymia Scale and the Symptom Check List 90 Revised somatization subscale. The validity analysis of the scale resulted in a very high significant difference (P < 0.01) between the mean SSAS scores of the control and patient's group. Test-retest, internal reliability, and item-total score correlation, discriminating power for specific groups and criterion related validity of the SSAS show that the scale has acceptable reliability and validity for the Turkish population.

Entities:  

Mesh:

Year:  2007        PMID: 17239035     DOI: 10.1111/j.1440-1819.2007.01606.x

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


  9 in total

1.  Determination of Anxiety, Health Anxiety and Somatosensory Amplification Levels in Individuals with Benign Paroxysmal Positional Vertigo.

Authors:  Alper Özdilek; Pınar Yalınay Dikmen; Erkan Acar; Elif Ayanoğlu Aksoy; Nazım Korkut
Journal:  J Int Adv Otol       Date:  2019-12       Impact factor: 1.017

2.  Prevalence of Psychiatric Comorbidity in Symptomatic Gastroesophageal Reflux Subgroups.

Authors:  Mustafa Melih Bilgi; Rukiye Vardar; Esra Yıldırım; Baybars Veznedaroğlu; Serhat Bor
Journal:  Dig Dis Sci       Date:  2016-08-26       Impact factor: 3.199

3.  Association between somatic amplification, anxiety, depression, stress and migraine.

Authors:  Burcu Goksan Yavuz; Elif Ilgaz Aydinlar; Pinar Yalinay Dikmen; Cem Incesu
Journal:  J Headache Pain       Date:  2013-06-25       Impact factor: 7.277

4.  The Relationship of Male Infertility with Somatosensory Amplification, Health Anxiety and Depression Levels.

Authors:  Ünal Öztekin; Yunus Hacimusalar; Abdullah Gürel; Ozgul Karaaslan
Journal:  Psychiatry Investig       Date:  2020-04-08       Impact factor: 2.505

5.  Clinical application of somatosensory amplification in psychosomatic medicine.

Authors:  Mutsuhiro Nakao; Arthur J Barsky
Journal:  Biopsychosoc Med       Date:  2007-10-09

6.  Evaluation of alexithymia, somatosensory sensitivity, and health anxiety levels in patients with noncardiac chest pain.

Authors:  Selma Bozkurt Zincir; Murat Sunbul; Esra Aydin Sunbul; Bahar Dalkilic; Fatma Cengiz; Tarik Kivrak; Erdal Durmus
Journal:  Biomed Res Int       Date:  2014-05-25       Impact factor: 3.411

7.  Validity of the French form of the Somatosensory Amplification Scale in a Non-Clinical Sample.

Authors:  Morgiane Bridou; Colette Aguerre
Journal:  Health Psychol Res       Date:  2013-03-22

8.  Reliability and Validity of the Farsi Version of the Somatosensory Amplification Scale.

Authors:  Alireza Aghayousefi; Mohammad Oraki; Narges Mohammadi; Valiyollah Farzad; Hammed Daghaghzadeh
Journal:  Iran J Psychiatry Behav Sci       Date:  2015-09-23

9.  Somatosensory Amplification, Anxiety, and Depression in Patients With Hepatitis B: Impact on Functionality.

Authors:  Ahmet Yilmaz; Feyzullah Ucmak; Süleyman Dönmezdil; Mehmet Cemal Kaya; Recep Tekin; Mehmet Günes; Necmi Arslan; Mahmut Bulut
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.